Curcumin and Cancer Research

Ajay Goel, PhD, director of epigenetics and cancer prevention at Baylor Research Institute discusses research and controversies surrounding curcumin

By Natural Medicine Journal

Printer Friendly PagePrinter Friendly Page

Ajay Goel, PhD, describes his research regarding curcumin and cancer, as well as his recent study involving patients with rheumatoid arthritis. Given recent controversies in curcumin research, Dr. Goel also summarizes the scientific validity of this botanical from a much broader perspective.

Approximate listening time is 15 minutes.

Ajay Goel, PhD, is director of epigenetics and cancer prevention at the Gastrointestinal Cancer Research Lab at Baylor Univeristy Medical Center in Dallas. He has spent 20 years researching cancer and has been the lead author or contributor to more than 100 scientific articles published in peer-reviewed international journals and several book chapters. He is currently researching the prevention of gastrointestinal cancers using integrative and alternative approaches, including botanical products. Two of the primary botanicals he is investigating are curcumin (from turmeric) and boswellia. Goel is a member of the American Association for Cancer Research and the American Gastroenterology Association and is on the international editorial boards of World Journal of Gastroenterology and World Journal of Gastrointestinal Oncology. He also performs peer-reviewing activities for almost 50 scientific journals and serves on various grant funding committees of the National Institutes of Health.


About the Author

Natural Medicine Journal is an electronic peer-reviewed journal and open access website dedicated to the field of integrative medicine.